Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

The expression of novel oncogenic kinase (NOK), a member of the protein tyrosine kinase (PTK) family, has been observed in several human malignancies including non-small cell lung cancer (NSCLC). However, the clinic relevance of NOK expression in NSCLC remains unclear.